How do SCFAs modulate cardiometabolic risk in normal-weight adults?

How SCFAs modulate cardiometabolic disease risk by interacting with an individual’s adiposity parameters and diet.

DB-1310 by Duality Biologics (Shanghai) for Non-Small Cell Lung Cancer: Likelihood of Approval

DB-1310 is under clinical development by Duality Biologics (Shanghai) and currently in Phase II for Non-Small Cell Lung Cancer.

December 7, 2023

CMS reworks drug price negotiation process with lawsuits top of mind

The Centers for Medicare and Medicaid Services on Friday took aim at lawsuits filed against its incoming drug price negotiations, with new final guidance on

July 1, 2023

Medicare Advantage insurers pressure Biden administration for bigger payments

The public will soon find out whether the federal government is willing to meet the health insurance industry’s demands and deposit more money into the

March 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.